Oramed Pharmaceuticals Total Current Liabilities 2011-2024 | ORMP

Oramed Pharmaceuticals total current liabilities from 2011 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.

Oramed Pharmaceuticals Total Current Liabilities 2011-2024 | ORMP

Oramed Pharmaceuticals total current liabilities from 2011 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$202.2B
Stryker (SYK)$143.3B
Boston Scientific (BSX)$130.1B
Medtronic (MDT)$112.5B
EssilorLuxottica (ESLOY)$111.7B
Lonza Group Ag (LZAGY)$45.4B
Haleon (HLN)$43.5B
GE HealthCare Technologies (GEHC)$39.3B
ResMed (RMD)$37B
Terumo (TRUMY)$29.6B
Koninklijke Philips (PHG)$25B
Zimmer Biomet Holdings (ZBH)$21.5B
Insulet (PODD)$18.8B
Baxter (BAX)$17.7B
Smith & Nephew SNATS (SNN)$10.6B
Bio-Rad Laboratories (BIO)$10.3B
BellRing Brands (BRBR)$9.1B
Demant (WILYY)$8.4B
Lantheus Holdings (LNTH)$6.1B
Haemonetics (HAE)$4.5B
TG Therapeutics (TGTX)$4.5B
ICU Medical (ICUI)$4.3B
Prestige Consumer Healthcare (PBH)$4B
Perrigo (PRGO)$3.6B
Neogen (NEOG)$3.5B
Envista Holdings (NVST)$3.5B
Agios Pharmaceuticals (AGIO)$3.4B
GN Store Nord (GNNDY)$3B
Shandong Weigao Medical Polymer (SHWGF)$3B
QuidelOrtho (QDEL)$2.9B